Yield10 Bioscience regains compliance with Nasdaq Minimum Bid Price Listing requirement
Woburn, Massachusetts, USA
January 31, 2020
Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience company that uses its “Trait Factory” to develop high value seed traits for the agriculture and food industries, announced today that it has received a letter from The Nasdaq Stock Market LLC notifying the Company that it has regained compliance with the Nasdaq Capital Market’s minimum bid price continued listing requirement. The letter noted that as of January 30, 2020, the Company evidenced a closing bid price of its common stock in excess of the $1.00 minimum requirement for at least ten consecutive trading days. Accordingly, the Company has regained compliance with Nasdaq Marketplace Rule 5550(a)(2) and Nasdaq considers the matter closed.
More news from: Yield10 Bioscience
Website: http://www.yield10bio.com Published: January 31, 2020 |
The news item on this page is copyright by the organization where it originated Fair use notice |